Cargando…

Abscopal effect in pulmonary carcinoid tumor following ablative stereotactic body radiation therapy: a case report

BACKGROUND: The abscopal effect was described as early as the 1950s, when untreated tumors demonstrated a response after radiation therapy was delivered to an untreated, distant site. The mechanisms underlying this global response to otherwise localized therapy remain unknown, though there is increa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kareff, Samuel A., Lischalk, Jonathan W., Krochmal, Rebecca, Kim, Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532944/ https://www.ncbi.nlm.nih.gov/pubmed/33010806 http://dx.doi.org/10.1186/s13256-020-02512-8

Ejemplares similares

Immune Modulation and Stereotactic Radiation: Improving Local and Abscopal Responses
por: Zeng, Jing, et al.
Publicado: (2013)

Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
por: Aghdam, Nima, et al.
Publicado: (2021)

Stereotactic body radiation therapy versus fractionated radiation therapy for early-stage bronchopulmonary carcinoid
por: Wegner, Rodney E, et al.
Publicado: (2019)

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
por: Kunos, Charles A., et al.
Publicado: (2015)

Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Salvage Prostate Stereotactic Body Radiation Therapy After Definitive Cryoablation
por: Lischalk, Jonathan W., et al.
Publicado: (2021)

Abscopal effect in metastatic breast cancer treated with stereotactic body radiotherapy in the absence of immunotherapy
por: Kim, Jae Sik, et al.
Publicado: (2023)

Gaseous nitric oxide tumor ablation induces an anti-tumor abscopal effect
por: Confino, Hila, et al.
Publicado: (2022)

Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors
por: Lischalk, Jonathan W., et al.
Publicado: (2018)

Rationale for Involved Field Stereotactic Body Radiation Therapy-Enhanced Intermittent Androgen Deprivation Therapy in Hormone-Sensitive Nodal Oligo-Recurrent Prostate Cancer Following Prostate Stereotactic Body Radiation Therapy
por: Carrasquilla, Michael, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy and Ablative Therapies for Solid Tumors: Recent Advances and Clinical Applications
por: Zhu, Jing, et al.
Publicado: (2019)

Surgical ablation after stereotactic body radiation therapy for ventricular arrhythmias
por: Hayase, Justin, et al.
Publicado: (2021)

Safety of stereotactic body radiation therapy for localized prostate cancer without treatment planning MRI
por: Amarell, Katherine, et al.
Publicado: (2022)

Stereotactic body radiation therapy for oligometastatic pulmonary tumors from cervical cancer
por: Hou, Xiaorong, et al.
Publicado: (2019)

Adrenergic stress constrains the development of anti-tumor immunity and abscopal responses following local radiation
por: Chen, Minhui, et al.
Publicado: (2020)

Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease
por: Lischalk, Jonathan W., et al.
Publicado: (2021)

Novel stereotactic body radiation therapy (SBRT)-based partial tumor irradiation targeting hypoxic segment of bulky tumors (SBRT-PATHY): improvement of the radiotherapy outcome by exploiting the bystander and abscopal effects
por: Tubin, Slavisa, et al.
Publicado: (2019)

Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate Cancer
por: Aghdam, Nima, et al.
Publicado: (2020)

Stereotactic body radiation therapy for an octogenarian with pulmonary carcinosarcoma
por: Huang, Wei‐Lun, et al.
Publicado: (2021)

Stereotactic ablative body radiation therapy for tumors in the lung in octogenarians: a retrospective single institution study
por: Cannon, Nathan A, et al.
Publicado: (2014)

Robotic Stereotactic Body Radiation Therapy for the Adjuvant Treatment of Early-Stage Breast Cancer: Outcomes of a Large Single-Institution Study
por: Jaysing, Anna, et al.
Publicado: (2022)

Abscopal Effect after Stereotactic Body Radiotherapy with Nivolumab for Lung Metastasis of Head and Neck Cancer: A Case Report
por: Endo, Masashi, et al.
Publicado: (2023)

Predictive factors of symptomatic radiation pneumonitis in primary and metastatic lung tumors treated with stereotactic ablative body radiotherapy
por: Kim, Kangpyo, et al.
Publicado: (2017)

Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?
por: Fernández, Castalia, et al.
Publicado: (2022)

Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy
por: Hsieh, Chen-Hsi, et al.
Publicado: (2014)

High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy
por: Carrasquilla, Michael, et al.
Publicado: (2022)

Bothersome Hematospermia Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Shah, Sarthak, et al.
Publicado: (2021)

Non-thermal histotripsy tumor ablation promotes abscopal immune responses that enhance cancer immunotherapy
por: Qu, Shibin, et al.
Publicado: (2020)

Radiofrequency Ablation Remodels the Tumor Microenvironment and Promotes Neutrophil-Mediated Abscopal Immunomodulation in Pancreatic Cancer
por: Faraoni, Erika Y., et al.
Publicado: (2023)

Spatiotemporal local and abscopal cell death and immune responses to histotripsy focused ultrasound tumor ablation
por: Pepple, Ashley L., et al.
Publicado: (2023)

Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma
por: Oldrini, Guillaume, et al.
Publicado: (2017)

Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer
por: Chen, Lily, et al.
Publicado: (2022)

Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery
por: Kim, Mi-Sook, et al.
Publicado: (2015)

Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer
por: Britschgi, Christian, et al.
Publicado: (2018)

The short-term outcomes of pulmonary metastasectomy or stereotactic body radiation therapy for pulmonary metastasis from epithelial tumors
por: Kanzaki, Ryu, et al.
Publicado: (2020)

Systemic benefit of radiation therapy via abscopal effect
por: Craig, Daniel J., et al.
Publicado: (2022)

Long-term outcomes of stereotactic body radiation therapy (SBRT) with fiducial tracking for inoperable stage I non-small cell lung cancer (NSCLC)
por: Lischalk, Jonathan W., et al.
Publicado: (2016)

Dysuria Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Janowski, Einsley-Marie, et al.
Publicado: (2015)

Proctitis following stereotactic body radiation therapy for prostate cancer
por: Joh, Daniel Y, et al.
Publicado: (2014)

Phase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation for Patients with Metastatic Castrate-Resistant Prostate Cancer
por: Hannan, Raquibul, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eg4uok1gj7dgg78rkcotentpkk